Abstract
This review is a brief but comprehensive overview on the multi-target profile of oleocanthal, an extra-virgin olive oil (EVOO) phenol corresponding to the (-)-decarboxymethylligstroside aglycone, speculating about its potential in the prevention and/or treatment of various diseases, such as neurodegeneration, inflammation and cancer.
Keywords: Olive oil, oleocanthal, biological targets, multi-pharmacological effect, cancer, inflammation, neurodegeneration.
Current Bioactive Compounds
Title:Multi-Target Profile of Oleocanthal, An Extra-Virgin Olive Oil Component
Volume: 12 Issue: 1
Author(s): Agostino Casapullo, Federica Del Gaudio, Angela Capolupo, Chiara Cassiano and Maria Chiara Monti
Affiliation:
Keywords: Olive oil, oleocanthal, biological targets, multi-pharmacological effect, cancer, inflammation, neurodegeneration.
Abstract: This review is a brief but comprehensive overview on the multi-target profile of oleocanthal, an extra-virgin olive oil (EVOO) phenol corresponding to the (-)-decarboxymethylligstroside aglycone, speculating about its potential in the prevention and/or treatment of various diseases, such as neurodegeneration, inflammation and cancer.
Export Options
About this article
Cite this article as:
Casapullo Agostino, Del Gaudio Federica, Capolupo Angela, Cassiano Chiara and Monti Chiara Maria, Multi-Target Profile of Oleocanthal, An Extra-Virgin Olive Oil Component, Current Bioactive Compounds 2016; 12 (1) . https://dx.doi.org/10.2174/1573407212666151231184806
DOI https://dx.doi.org/10.2174/1573407212666151231184806 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Atorvastatin Therapy Lowers Circulating Cholesterol but not Free Radical Activity in Advance of Identifiable Clinical Benefit in the Treatment of Mild-to-Moderate AD
Current Alzheimer Research Ganoderma lucidum (Ling-zhi): The Impact of Chemistry on Biological Activity in Cancer
Current Bioactive Compounds Light-at-Night-Induced Circadian Disruption, Cancer and Aging
Current Aging Science Controlled Release of Growth Factors for Regenerative Medicine
Current Pharmaceutical Design Exosomes and Exosomal microRNAs in Age-associated Stroke
Current Vascular Pharmacology Cardiac (myo)fibroblast: Novel Strategies for its Targeting Following Myocardial Infarction
Current Pharmaceutical Design Emergent Balloon Mitral Valvuloplasty During Pregnancy: A Case Report
Current Women`s Health Reviews Key Proteins in the Polyamine-Trypanothione Pathway as Drug Targets Against Trypanosoma cruzi
Current Medicinal Chemistry Patent Selections
Recent Patents on Cardiovascular Drug Discovery Acute Stroke Therapy: Combination Drugs and Multifunctional Neuroprotectants
Current Neuropharmacology Platelet Activation, Inflammatory Mediators and Hypercholesterolemia
Current Vascular Pharmacology Impact of Oral 1,25-Dihydroxy Vitamin D (Calcitriol) Replacement Therapy on Coronary Artery Risk Factors in Type 2 Diabetic Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets Statins and Left Ventricular Function
Current Pharmaceutical Design Echocardiogram versus Cardiac Magnetic Resonance Imaging for the Diagnosis of Non-compaction Cardiomyopathy – A Case Report
New Emirates Medical Journal Optimized Turmeric Extracts have Potent Anti-Amyloidogenic Effects
Current Alzheimer Research G-Protein Coupled Receptors (GPCRs): A Comprehensive Computational Perspective
Combinatorial Chemistry & High Throughput Screening Editorial: Ischemic Stroke Prevention
Current Vascular Pharmacology CRP Pro-inflammatory Signalling in Atherosclerosis: Myth or Reality?
Current Signal Transduction Therapy Sphingosine 1-Phosphate in Vascular Biology: Possible Therapeutic Strategies to Control Vascular Diseases
Current Pharmaceutical Design Xanthine Derivatives in the Heart: Blessed or Cursed?
Current Medicinal Chemistry